Global Lancets Market Overview

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
 
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
 
In the last several years, global market of Lancets developed year by year, with an average growth rate of 6.9% for the sales. In 2016, global revenue of Lancets is nearly 1260 M USD; the sale is about 47 billion units.
 
The classification of Lancets includes Safety Lancets, Homecare Lancets. The proportion of Homecare Lancets in 2016 is about 78.6%, and the proportion is in decreasing trend from 2012 to 2016. The Safety Lancet is enjoying more and more market share.
 
Lancets are widely used in cholesterol tests, glucose tests and other tests. The more than half of lancets is used in glucose test, and the sales proportion in 2016 is about 75%, but the Lancets used in cholesterol test is enjoying more and more market share.
 
According to WHO, The number of people with diabetes has risen from 108 million in 1980 to 450 million in 2016, The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.7% in 2016, Diabetes prevalence has been rising more rapidly in middle- and low-income countries. Affected by demand, there is a rapid increase of lancets industry. During 2012--2017, lancets industry kept increasing at a high speed, which in China CAGR is 6.5% in 2012-2017. In the next few years, lancets industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

GlobalInfoResearch All Rights Reserved